Clinical trial
A Three-arm Randomized Controlled Non-inferiority Pilot Study Comparing Anticoagulation Strategies Using Unfractionated Heparin, Argatroban and Low-molecular-weight Heparin for Extracorporeal Membrane Oxygenation Support
NCT06442267 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Three-arm Randomized Controlled Non-inferiority Pilot Study Comparing Anticoagulation Strategies Using Unfractionated Heparin, Argatroban and Low-molecular-weight Heparin for Extracorporeal Membrane Oxygenation Support
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- July 30, 2024
- Completion date
- July 30, 2027
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bleeding, circulatory failure, respiratory insufficiency, thromboembolism